Antidotal potency of the novel, structurally different adsorbents in rats acutely intoxicated with the T-2 toxin by Jaćević, Vesna et al.
toxins
Article
Antidotal Potency of the Novel, Structurally Different
Adsorbents in Rats Acutely Intoxicated with the
T-2 Toxin
Vesna Jac´evic´ 1,2,3,*,† , Jelena Dumanovic´ 2,4,† , Miodrag Lazarevic´ 5 ,
Eugenie Nepovimova 3 , Radmila Resanovic´ 6, Zoran Milovanovic´ 7, Qinghua Wu 3,8 and
Kamil Kucˇa 3,*
1 Department for Experimental Toxicology and Pharmacology, National Poison Control Centre,
Military Medical Academy, 11000 Belgrade, Serbia
2 Department of Pharmacological Science, Medical Faculty of the Military Medical Academy,
University of Defence, 11000 Belgrade, Serbia; dumanovicjelena@gmail.com
3 Department of Chemistry, Faculty of Science, University of Hradec Kralove,
Rokitanského 62 500 03 Hradec Králové, Czech Republic; evzenie.n@seznam.cz (E.N.);
wqh212@hotmail.com (Q.W.)
4 Department of Analytical Chemistry, Faculty of Chemistry, University of Belgrade, 11158 Belgrade, Serbia
5 Department for Physiology, Faculty of Veterinary Medicine, University of Belgrade, 11000 Belgrade, Serbia;
lazarevicm@vet.bg.ac.rs
6 Institute for Poultry Disease, Faculty of Veterinary Medicine, University of Belgrade, 11000 Belgrade, Serbia;
radar@vet.bg.ac.rs
7 Special Police Unit, Police Department of the City of Belgrade, Ministry of Interior, 11030 Belgrade, Serbia;
tinahoks41@gmail.com
8 College of Life Science, Yangtze University, Jingzhou, Hubei 434023, China
* Correspondence: v_jacevic@yahoo.com (V.J.); kamil.kuca@uhk.cz (K.K.);
Tel.: +381-69-172-3486 (V.J.); +420-603-289 (K.K.)
† Equal contribution.
Received: 31 August 2020; Accepted: 2 October 2020; Published: 5 October 2020


Abstract: In this paper, the potential antidote efficacy of commercially available formulations
of various feed additives such as Minazel-Plus®, Mycosorb®, and Mycofix® was considered by
recording their incidence on general health, body weight, and food and water intake, as well as
through histopathology and semiquantitative analysis of gastric alterations in Wistar rats treated
with the T-2 toxin in a single-dose regimen of 1.67 mg/kg p.o. (1 LD50) for 4 weeks. As an organic
adsorbent, Mycosorb® successfully antagonized acute lethal incidence of the T-2 toxin (protective
index (PI) = 2.25; p < 0.05 vs. T-2 toxin), and had adverse effects on body weight gain as well as food
and water intake during the research (p < 0.001). However, the protective efficacy of the other two
food additives was significantly lower (p < 0.05). Treatment with Mycosorb® significantly reduced
the severity of gastric damage, which was not the case when the other two adsorbents were used.
Our results suggest that Mycosorb® is a much better adsorbent for preventing the adverse impact of
the T-2 toxin as well as its toxic metabolites compared with Minazel-plus® or Mycofix-plus®, and it
almost completely suppresses its acute toxic effects and cytotoxic potential on the gastric epithelial,
glandular, and vascular endothelial cells.
Keywords: T-2 toxin; adsorbents; rats; antidote
Key Contribution: The antidotal potency of Minazel-plus®, Mycosorb®, and Mycofix-plus® (each
applied as a single dose of 1.0 g/kg p.o.) was evaluated in Wistar rats treated with the T-2 toxin in a
single-dose regimen of 1.67 mg/kg p.o. (1 LD50) by recording the general health condition, survival
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rate, protective index, body weight gain, food and water consumption, and gastric damage score over
4 weeks.
1. Introduction
T-2 mycotoxin is a particularly toxic natural metabolite of various fungi from the genus
Fusarium [1–3]. Under specific storage conditions, namely a high temperature and high humidity, these
moldy species may infect the majority cereal grains [4–7]. The oral intake of naturally infected food
and feed with various toxic parts of Fusarium fungi can result in severe mycotoxicosis with signs of
intoxication similar to T-2 toxin effects [8–12]. In humans and animals, the T-2 toxin causes general signs
of the so-called shock-like syndrome, accompanied with emesis, lowered weight gain, lethargy, bloody
diarrhea, gastric and intestinal disorders, haemorrhaging, immunosuppression, cardiomyopathy,
and finally death [13–18]. Furthermore, similarly to acute radiation syndrome [19–21], inflammatory
reaction, caused by the T-2 toxin, is a consequence of phospholipase A2 activation, successive
prostaglandins, and reactive oxygen species (ROS) production [15,22,23]. Intensive accumulation of
ROS may lead to DNA damage, protein oxidation, and lipid peroxidation [24–26]. Consequently,
if lipid peroxidation is progressive, free radical generation and neutrophils infiltration of gastric
mucosal tissue are tangled within the progression of acute gastric lesions [9,27,28]. As the T-2 toxin is
extremely cytotoxic, it can break the conventional gastrointestinal entity both in vitro and in vivo [29].
There is a strong belief that T-2 toxic effects are a consequence of certain subcellular changes [4,5,30,31].
Thus, during a histopathology examination of the gastrointestinal tissue of rats, prominent mucosal
lesions in an exceeding sort of petechiae and ulcerations were determined, presumably because of
augmented capillary permeability and hemorrhages, and therefore a build-up of cells involved in
inflammation was noted [32–34].
As mentioned earlier, these intensive gastric injuries are not only thanks to a local toxic effect [9,20],
but to biliary excretion and enterohepatic recirculation of the T-2 and HT-2 toxins as well, [15,21]
causing generalized toxic effects [34]. By providing the previously demonstrated mechanism of gastric
toxicity induced by the T-2 toxin, an approach that supports the use of adsorbents seems to be rational.
Numerous studies have shown that treatment with different adsorbents in clinical practice leads to a
significant reduction and/or elimination of the adverse effects of varied mycotoxins [35–40]. In those
studies, adsorbents, as substances unlikely to be absorbed from the intestine, have an exquisite potential
to bind natural chemicals to themselves, thus preventing their absorption. To date, an outsized number
of adsorbents, like activated charcoal, esterified glucomannan, various clays, and aluminosilicate zeolite,
have shown significant protective effects against T-2 toxin acute intoxication, both in experimental
studies and in clinical practice [41–43]. It has been shown that these inorganic adsorbents, as additives
for the decontamination of food or feed, show selective binding of T-2 mycotoxins, preventing the
passage of this toxin through the alimentary tract without adverse effects on general health, as well
as its distribution in animal’s tissues or organs, which are used as edible nutrients for the human
population. Moreover, inorganic adsorbents can fully bind aflatoxins, and are principally proposed
to reduce their toxic effects [35,36,39,40]. During recent years, specific treatment using organic feed
additives, such as modified mannan oligosaccharides, originating from the yeast cell wall inner layer,
have been examined. Essentially, biological detoxification of the T-2 toxin is perhaps facilitated by the
activity of the microorganism’s whole cells or the certain enzymes of only one cell [44].
Considering the above-mentioned findings, we have conducted a comprehensive study to gauge
the potential antidotal efficacy of the commercially available formulation of the three various feed
additives, namely Minazel-Plus® (an inorganic-modified clinoptilolite), Mycosorb® (an organic-esterified
glucomannan), and Mycofix® (a combined), by recording their incidence on general health, body weight,
and food and water intake, and through histopathology and semiquantitative analysis of gastric alterations
in Wistar rats acutely poisoned by the T-2 toxin.
Toxins 2020, 12, 643 3 of 15
2. Results
2.1. The Experimental Animals’ General Condition
Characteristic clinical symptoms of serious intoxication (i.e., vomiting, emesis, feed refusal,
diarrhea, decreased body surface temperature, lethargy, and weakness) were only noticed in the
group of animals treated with the T-2 toxin over a period of 2 to 4 days. Thereafter, no significant
changes in the general health condition were observed in the surviving animals over the 28-day
observation period.
Moreover, the absence of serious behavioral and gastrointestinal disorders was observed
in the surviving rats from the groups protected with Minazel-Plus® (MP), Mycosorb® (MS),
and Mycofix-plus® (MF) over the 28-day observation period.
Moreover, these animals had been in a proper health condition, without any visible changes to the
skin and mucosal membranes.
2.2. The Influence of Various Adsorbents on the Survival Rate in the T-2 Toxin-Treated Animals
By monitoring the survival rate after 24 h, we found that all of the applied adsorbents successfully
antagonized the lethal effects of the T-2 toxin, but only at the highest dose (1.0 g/kg).
As presented in Table 1, the best protective index was accomplished with Mycosorb® (2.25), with
a value significantly higher than 1.31 and 1.79 rendered following treatment with the same total single
dose of Minazel-Plus® and Mycofix-plus®, respectively.
Table 1. The protective effects of Minazel-Plus® (MP), Mycosorb® (MS), and Mycofix-plus® (MF) on
the 24-h survival in T-2 toxin-treated rats.
Treatment LD50 95% Confidence Limit f(LD50) Protective Index (PI)
T-2 1.67 1.27–2.19 1.31 -
T-2 + MP 2.18 1.77–2.88 1.36 1.31
T-2 + MS 3.75 3.08–4.42 1.35 2.25
T-2 + MF 2.98 2.28–3.52 1.51 1.79
LD50 was calculated according to Litchfield and Wilcoxon. Protective indexes were calculated according to the
following equation: PI = LD50 (T-2 + adsorbent)/LD50 (T-2).
These protective effects established after 24 h remain at the same level throughout the 28 days of
the experiment.
In this part of the study, the comparative protective efficacy of Minazel-Plus® (MP), Micosorb®
(MS), and Mycofix-plus® (MF) was also examined. All of the adsorbents given at a dose of 1.0 g/kg
resulted in good protection. A single dose of Minazel-Plus® (MP) and Micofix-plus® (MF) provided
a survival rate of 65% and 75%, respectively, 24 h after T-2 toxin intoxication, while the survival
rate of Micosorb® (MS) animals was 90%. There was no statistically significant difference between
the groups treated with Minazel-Plus® (MP) and Mycofix-plus® (MF). Moreover, the survival rates
showed a statistical significance between Micosorb® (MS) and Minazel-Plus® (MP), as well as between
Micosorb® (MS) and Mycofix-plus® (MF), throughout the study period (p < 0.5; Figure 1).
Toxins 2020, 12, 643 4 of 15
Figure 1. Time-dependent effects of Minazel-Plus® (MP), Mycosorb® (MS), and Mycofix-plus® (MF)
on the survival rates in T-2 toxin-treated rats: (a) p < 0.05 vs. Minazel-Plus® (MP); (b) p < 0.05 vs.
Mycofix-plus®.
2.3. The Influence of Various Adsorbents on Body Weight Gain in T-2 Toxin-Treated Animals
According to the data presented in Figure 2, the T-2 toxin induced a huge reduction in body
weight compared with the control groups, with the lowest data being shown on the seventh day of this
experiment (p < 0.001). Moreover, a mild increase in weight gain was registered from days 14 to 28, but it
was significantly less than within the groups protected with Mycosorb® (p < 0.001), Minazel-Plus®,
and Mycofix-plus® (p < 0.01). The best body weight was accomplished with Mycosorb®, and with
values almost the same as for the control animals and notably above than those within the T-2
toxin-poisoned group (p < 0.001). Furthermore, a marked upgrowth of body mass was established
within the Minazel-Plus®- and Mycofix-plus®-protected groups, with values significantly above those
obtained within the unprotected group (p < 0.01). Moreover, body weight gain in these groups was
significantly slower compared with the control group and Mycosorb®-treated group (p < 0.05).
2.4. The Influence of Various Adsorbents on Food Consumption in T-2 Toxin-Treated Animals
As presented in Figure 3, in the group of rats treated with only the T-2 toxin, a major reduction
in food consumption was noticed one week after intoxication. Afterwards, a humble increase in
food consumption was registered throughout the study period, with values significantly less than
those for the control group (p < 0.001). On the contrary, the calculated values of food consumption
in rats protected with Mycosorb® were very almost the same as those within the control group of
rats throughout the trial (p < 0.001). However, in the Minazel-Plus®- and Mycofix-plus®-treated
group, a moderate increase in food consumption was registered during days 7 to 14; however, their
values were slightly above those from the poisoned group of animals (p < 0.05). Hence, in these
two experimental groups, by the end of the study, food consumption was almost the same in the T-2
toxin-treated groups.
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Figure 2. Time-dependent effects of Minazel-Plus® (MP), Mycosorb® (MS), and Mycofix-plus® (MF)
on body weight in T-2 toxin-treated rats (T-2): (a3) p < 0.001 vs. control; (b1, b2, b3) p < 0.05, 0.01, 0.001,
respectively, vs. the T-2 toxin.
Figure 3. Time-dependent effects of Minazel-Plus® (MP), Mycosorb® (MS), and Mycofix-plus® (MF)
on food consumption in T-2 toxin-treated rats (T-2): (a2, a3) p < 0.01, 0.001, respectively, vs. control;
(b1, b3) p < 0.05, 0.001, respectively, vs. T-2 toxin.
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2.5. The Influence of Various Adsorbents on Water Consumption in T-2 Toxin-Treated Animals
The results presented in Figure 4 clearly show that a complete single dose of Mycosorb® initially
significantly increased the quantity of consumed water compared with the poisoned animals (p < 0.001).
Interestingly, these values were gently above those observed within the control group during the
first three weeks of the study. Furthermore, treatment with Minazel-plus® and Mycofix-plus® also
increased water consumption, but these differences were less pronounced (p < 0.05) in comparison
with the poisoned and unprotected rats.
Figure 4. Time-dependent effects of Minazel-Plus® (MP), Mycosorb® (MS), and Mycofix-plus® (MF)
on water consumption in T-2 toxin-treated rats (T-2): (a3) p < 0.001 vs. control; (b1, b3) p < 0.05, 0.001,
respectively, vs. T-2 toxin.
2.6. The Influence of Various Adsorbents on Gastric Damage of T-2 Toxin-Treated Animals
The gastric tissue samples of the control rats had a histological structure without lesions (Figure 5a).
After seven days of subsequent treatment, in the poisoned and unprotected animals, segmental
degeneration, moderate hemorrhagic foci, and collections of neutrophils, macrophages, and mast
cells (MCs) in the tunica submucosa were recorded (Figure 5b). The intensity of the described tissue
alterations was increased on the 28th day of treatment, and their appearance was noticed diffusely
(Figure 5c). Furthermore, on the day 28 of the trial, the T-2 toxin was triggered with a prominent lack of
epithelial layer, submucosal oedema, reduced gastric pits, cystically altered gastric glands, and a large
collection of inflammatory cells. A single application of Minazel-Plus®, Mycosorb®, or Mycofix-plus®
visibly reduced the intensity of the gastric injuries, the extent of intestinal bleeding, and the prevalence
of inflammatory cells after 7 days (Figure 5d–f). However, at the end of the research period, the mildest
degenerative alterations, focal haemorrhages, and single accumulation of inflammatory cells were
observed in the poisoned rats protected with Mycosorb® (Figure 5h) when compared with the group
treated with Minazel-plus® (Figure 5g) or Mycofix-plus® (Figure 5i).
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Figure 5. Gastric micrographs of rats treated with the T-2 toxin (T-2) and protected with Minazel-Plus®
(MP), Mycosorb® (MS), and Mycofix-plus® (MF); H&E staining, magnification 200×, scale bar = 50 µm:
(a) control group, a gastric wall with no visible damage; (b) 7 days after treatment with T-2, ulceration
in the lamina epithelial; (c) 28 days after treatment with T-2; cystic deformation of the gastric glands;
(d) 7 days after treatment with T-2 + MP, erosions in the superficial epithelium; (e) 7 days after
treatment with T-2 + MS, hyperemia and transmural oedema; (f) 7 days after treatment with T-2 + MF,
degeneration of the epithelial and glandular cells; (g) 28 days after treatment with T-2 + MP, partial
atrophy of the gastric pits; (h) 28 days after treatment with T-2 + MS, enlarged gastric pits; (i) 28 days
after treatment with T-2 + MF, squamous degeneration of the epithelial cells.
2.7. A Semiquantitative Evaluation of the Influence of Various Asorbents on the Gastric Damage of T-2
Toxin-Treated Animals
A detailed semiquantitative analysis proved that Mycosorb® reduces the enormous gastric
cell damage that occurred in the poisoned animals throughout the 28 days of the trial (Table 2).
In the protected rats, the gastric damage score (GDS) was significantly lower when compared with the
poisoned group only, starting on the seventh day of examination (p < 0.05). Additionally, the established
damage was significantly higher when compared with the control animals throughout the research
(p < 0.05). Therefore, the gastric damage detected in the poisoned rats treated with Minazel-plus®
ranged from exfoliation of the superficial epithelium (GDS = 2.80, day 7) to pronounced ulcerations,
haemorrhages, and inflammatory cells infiltrations (GDS = 4.20, day 28). Quite similar gastroprotective
effects were seen within the poisoned group protected with Mycofix-plus®, and the GDS values were
2.70 and 3.20, respectively.
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Table 2. The protective effects of Minazel-Plus® (MP), Mycosorb® (MS), and Mycofix-plus® (MF) on
the severity of T-2 toxin-induced gastric changes in rats—gastric damage score (GDS).
Treatments
GDS (Mean Number (X ± SD)
(4 Stomachs/Group × 8 Slices/Stomach))
7th day 28th day
Control 0.2 ± 0.4 0.2 ± 0.4
T-2 3.5 ± 0.5 a 4.2 ± 0.4 a
T-2 + MP 2.8 ± 0.4 a 3.5 ± 0.5 a
T-2 + MS 1.5 ± 0.5 a,b 2.1 ± 0.3 a,b
T-2 + MF 2.7 ± 0.3 a 3.2 ± 0.4 a
Tuckey’s test was applied for statistical analysis; (a) p < 0.05 vs. control, (b) p < 0.05 vs. T-2.
3. Discussion
Consistent with our previously published results, the T-2 toxin certainly leads to acute gastric
mucosal damage [20,45]. The calculated LD50 value of 1.67 mg/kg p.o. was also in agreement with the
data of other authors, verifying that its acute toxicity, depending on the animal species and application
mode, was in an exceedingly wide range (i.e., 0.5–10.5 mg/kg) [3,10,46]. Additionally, when the T-2
toxin was administered orally, gastric damage occurred directly by toxic influence on the tunica mucosa,
and partially by indirect excretion of its toxic metabolites from the hepatobiliary system [20,29,47].
In this regard, we found typical clinical signs of intoxication in rats like vomiting, emesis, food
refusal, diarrhea, decreased body surface temperature, lethargy, and weakness after 4 days of T-2
toxin administration at a single dose of 1.67 mg/kg p.o. Namely, the described clinical signs exhibited
by the T-2 toxin-poisoned animals were similar to the symptoms reported earlier in calves [48,49],
sheep [50], pigs [51], and goats [34]. Typical symptoms of T-2 toxicosis in lambs were expressed in the
form of recurrent diarrhea associated with infection of the Eimeria species [50]. Additionally, particular
symptoms observed during T-2 toxin intoxication, like lethargy and feed refusal, could be due to
impairment within the central nervous system [52]. Partial or complete feed refusal, prolonged bloody
diarrhea, and decreased gastrointestinal absorptive capacity were also registered in cattle [53–55].
Because of the complete refusal of feed, reduction of protein synthesis, and consequent weight loss,
many organs were damaged, primarily the kidneys and liver, as well as the gastrointestinal and
lymphatic tissue [4,34]. As noted by other scientists [42,44], we also observed a complete absence of
previously mentioned clinical signs of T-2 toxin intoxication following the therapeutic administration
of Mycosorb®, Minazel-Plus®, and Mycofix-plus® over the whole research period.
Furthermore, in our previous studies, Mycosorb®, Minazel-Plus®, and Mycofix-plus®, given in
the same dose, showed a promising protective potential against the adverse influence of the T-2 toxin
in rats [18,19,45]. Throughout this study, Mycosorb® administered at the same dose of 1 g/kg p.o.,
shortly after treatment with the T-2 toxin, significantly reduced the LD50 value (Table 1), indicating that
the applied dose was very safe and therapeutically effective only in case of T-2 poisoning. Moreover,
Mycosorb® had the highest protective index (PI = 2.25), which was well above the 1.31 and 1.79 obtained
following treatment with Minazel-Plus® and Mycofix-plus®, respectively. In this manner, Mycosorb®
showed a high capacity for suppressing the T-2 toxin’s lethal outcomes. A lack of similar effects after the
same dose of Minazel-Plus® and Mycofix-plus® might be caused by the lower adsorptive properties
within the gastrointestinal tract. This process could potentiate the direct local toxic effect of the T-2
toxin and its active metabolites after enterohepatic recirculation, thus disrupting the protective effects
of Minazel-Plus® and Mycofix-plus®. The lack of a full protective potential of Minazel-Plus® and
Mycofix-plus® to completely prevent T-2 toxin intoxication may be explained by the fact that inorganic
materials such as activated charcoal, clay, bentonite, and aluminosilicate (principally proposed to
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reduce the toxic effects of aflatoxins) [35,36,39,40], have a limited efficacy relative to other toxins [38].
Moreover, almost all inorganic adsorbents contain dioxin and heavy metals, which are toxic.
On the other hand, organic adsorbents like Mycosorb® have consequently been recommended as
an alternative solution to adsorb numerous mycotoxins, including the T-2 toxin, but without spoiling
the nutrient bioavailability or inducing adverse health effects in animals [56]. In agreement with other
researchers, we observed [34,37,42,44] a significant lowering of the rats’ body weight and food and
water consumption from the first week after the application of T-2 toxin. Although the body mass
and food and water consumption of the Minazel-Plus®- and Mycofix-plus®-treated rats were also
markedly decreased in comparison with the control animals, it was still greater than in the group
treated with the T-2 toxin only, especially during the last three weeks of the trial. When a relatively high
single dose of the T-2 toxin was administered, a significant decrease in body weight and food and water
consumption was observed compared with the control group [19,44]. This could be explained by the
loss of appetite, complete feed refusal, and substantial lesions in the tunica mucosa of the gastrointestinal
tract accompanied by prolonged bloody diarrhea, which prevented food and water intake and its
utilization [45,54,55].
Furthermore, the T-2 toxin leads to segmental degeneration, moderate hemorrhagic foci,
and infiltration of gastric mucosal inflammatory cells over seven days (3.5 ± 0.5). The overall
number of gastric mucosal injuries accompanied by petechiae and ulcerations was slightly higher
after 28 days (4.2 ± 0.4). As mentioned earlier, gastric mucosa alterations are not only generated
because of direct local toxic effects [9,10,29], but are also a consequence of the T-2 toxin and its active
metabolites’ biliary excretion and enterohepatic recirculation causing general toxic effects [9,15,47].
Moreover, a single treatment with Minazel-Plus®, Mycosorb®, and Mycofix-plus® visibly reduced
the intensity of the gastric mucosa injuries, hemorrhagic foci, and prevalence of inflammatory cells
after seven days of the study (GDS = 1.5 ± 0.5, 2.7 ± 0.3, and 2.8 ± 0.4). It was shown that the mildest
degenerative and vascular alterations, as well as inflammation of the cell’s foci, were observed in
the poisoned rats protected with Mycosorb® (2.1 ± 0.3) when compared with the group treated with
Minazel-plus® (3.5 ± 0.5) or Mycofix-plus® (3.2 ± 0.4) at the end of the research period. These results
support the claim that aluminosilicates, as dietary supplements, do not fully protect animals from the
harmful effects of T-2 toxins [44,57,58]. Namely, aluminosilicates are generally able to absorb almost all
aflatoxins, while in others with chemically different mycotoxins, they exhibited a partial or incomplete
adsorption potential [59]. On the other hand, Mycofix-plus®, as a mixed feed additive, contains the
enzyme de-epoxidase, which selectively binds to the 12,13-epoxy-trichothecene ring of the T-2 toxin,
thereby initiating the deacetylation process and its transformation into a less toxic de-epoxy-HT-2
toxin, making it a more potent adsorbent compared with aluminosilicates [60]. Given together with
the T-2 toxin, the organic adsorbent Mycosorb® expressed a significant decrease in the occurrence
of cytotoxic alteration for both gastric epithelial and glandular cells, as well as vascular endothelial
cells, over the 4-week study period. The ligands, mainly β-D-glucans, derived from the yeast cell’s
wall, expressed the most potent functional efficiency in forming a complex with various mycotoxins in
naturally or artificially contaminated animal feed [56,61–64]. It is assumed that the protective role of
the applied organic adsorbent is a consequence of generating a tight biological complex with the T-2
toxin or its active metabolites, suppressing their negative impact on the gastric mucosal cells, and thus
alleviating the production of pro-inflammatory substances [9,17,18] and the further release of reactive
oxygen species and cytokines (TNF-α, IL-1, and IL-6) [21,65,66] as crucial mediators of oxidative stress
and further development of the inflammatory reaction.
4. Conclusions
These results suggest that Mycosorb®, compared with Minazel-plus® or Mycofix-plus®, is a much
better adsorbent for preventing the adverse impact of the T-2 toxin, as well as its toxic metabolites,
and it almost completely suppress its acute toxic effects and cytotoxic potential on the gastric epithelial,
glandular, and vascular endothelial cells.
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5. Materials and Methods
5.1. Experimental Animals
In this trial we used 6–8 week old (200–220 g) adult Wistar rats, raised at the Institute for
Biomedical Researches, Military Medical Academy, Belgrade, Serbia. A typical macrolon plastic cage
(Bioscape, Germany) filled with clear sawdust (Versele-Laga, Deinze, Belgium) was used for housing
the experimental animals. The animals were housed in centrally regulated ambient conditions, with a
temperature of 22 ± 2 ◦C, humidity of 55 ± 15%, air changes/h of 15–20, and light/dark cycle of 12/12 h.
A commercial diet mixture for rats (Veterinary Institute Subotica, Subotica, Serbia) and tap water
were applied ad libitum. Before the start of the study, the experimental design, laboratory protocol,
and welfare of the experimental animals were approved by the Ethics Committee of Experimental
Animals of the Military Medical Academy, Belgrade, Serbia (no. 282-12/2002, date: 2 December 2002.).
This decision confirmed that the complete experimental study, animal care, and all of the treatments
throughout the research are in compliance with Directive 2010/63/EU for the protection of animals
used for scientific purposes, as well as the Guidelines for Animal Welfare adopted by the Republic of
Serbia (no. 323-07-04943/2014-05/1; date: 8 December 2014).
5.2. T-2 Toxin
The T-2 toxin was isolated from Fusarium sporotrichoides fungi (ITM-391, originated from Serbian
cereals in an accredited laboratory (Center of the Bio-Ecology, Zrenjanin, Republic of Serbia) [67–69],
as previously described [9].
The T-2 toxin was applied in a single total dose of 1.67 mg/kg p.o., as previously described [9,17,18,70].
5.3. Various Commercial Adsorbents
In this study, three commercially available formulations of the following adsorbents were used:
(1) Minazel-plus® (MP; Patent Komerc, Mišic´evo, Serbia), as an inorganic adsorbent obtained by organic
modification of natural zeolite; (2) Mycosorb® (MS; Alltech, Geneva, IL, USA), organic adsorbent based
on esterified glucomannan derived from Saccharomyces cerevisiae 1026; and (3) Mycofix-plus® (MF;
Biomin, Herzogenburg, Austria), a mixed multi-component adsorbent composed of microorganisms
(i.e., genus novus of the family Coriobacteriaceae), enzymes, and plant phycophytes.
Directly before p.o. application, each adsorbent was dissolved in a commercially prepared NaCl
solution (0.9%), extempore.
5.4. Protective Effects of Commercial Adsorbents
For the purpose of determining the protective effects of Minazel-plus® (MP), Mycosorb® (MS),
and Mycofix-plus® (MF), the animals were poisoned by applying increasing doses of the T-2 toxin p.o.
(0.75, 1.5, and 2.25 mg/kg p.o.). Following p.o. application, increasing doses of each adsorbent were
applied (0.5, 0.75, and 1.0 g/kg).
The mean lethal doses were calculated after 24 h [18,45], and afterwards, the protective indexes (PIs)
were calculated according to the previously published equation of PI = LD50 (T-2 toxin + adsorbent)/LD50
(T-2 toxin) [9]. Survival was monitored over a period of 28 days after treatment. The percentage of survival
for all of the poisoned and then protected animals was calculated [45].
As already shown [18,45], in the rats treated with increasing doses of the T-2 toxin, the best
protective effects were achieved by applying the highest single dose of each adsorbent (1.0 g/kg p.o.).
These protective effects established at 24 h remained at the same level throughout the 28 days of the
experiment. Accordingly, the same dose of each adsorbent was chosen for the rest of this study.
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5.5. Experimental Design
After randomization, animals from five experimental groups, with 16 animals per group, were
treated as follows: (1) control (0.9% saline 1 mL/kg p.o.), (2) T-2 toxin (T-2, 1.67 mg/kg p.o.), (3) T-2
toxin (T-2, 1.67 mg/kg p.o.) and Minazel-plus® (MP, 1 g/kg p.o.), (4) T-2 toxin (T-2, 1.67 mg/kg p.o.) and
Mycosorb® (MS, 1 g/kg p.o.), and (5) T-2 toxin (T-2, 1.67 mg/kg p.o.) and Mycofix-plus® (MF, 1 g/kg
p.o.). First, the experimental animals were treated with the T-2 toxin, and immediately afterwards they
were administered the examined adsorbents.
Then, the antidotal efficacy of each adsorbent was assessed by recording its influence on general
health, body weight, and food and water intake in the T-2 toxin treated rats, over the whole 4-week
study period.
5.6. Histopathological Examination
In a separate experiment of the same design, the gastric tissues of four rats from each experimental
group were taken 7 and 28 days after treatment, and were prepared for histopathological analysis.
Specifically, four surviving animals from each experimental group were sacrificed, through
anaesthetic by light ether, and each of the gastric samples were fixed in neutral buffered formalin (10%)
for 5 to 7 days. Thereafter, six tiny slices from each gastric sample were dehydrated using xylene,
a graded alcohol solution, and they were placed into paraffin blocks.
Each 2-µm thick paraffin section was stained with hematoxylin and eosin (H&E), and exanimated
at a magnification of 200× using a light microscope (BKS-45, Olympus, Japan), according to our
previously published methodology [9,17–20,71–77].
5.7. Semiquantitative Analysis
By using a light microscope, the distinctive gastric damage was analyzed and counted in
accordance with a five-point semiquantitative scale developed for the assessment of the gastric damage
score—gastric damage score (GDS; Table 3).
Table 3. Histopathological scoring scale for gastric damage in treated rats—gastric damage score (GDS).
Grade Definition
0 Normal histological structure of the stomach
1 Mild alteration: segmental loss of the superficial epithelium, discrete vasodilatation of the bloodvessels, and single inflammatory cells
2 Moderate damage: exfoliation of the surface epithelium, strong vasodilatation of the blood vessels,and inflammatory cell infiltration
3 Severe, focal damage: erosion of the epithelium, hemorrhages, and inflammatory cell infiltration
4 Severe, diffuse damage: pronounced ulcerations, hemorrhages, and inflammatory cell infiltration
5 Tissue necrosis
5.8. Statistical Analysis
A careful statistical examination was performed using commercial statistical software (Stat for
Windows, R.7, Stat Soft, Inc., Tulsa, OK, USA, 2008). In the tables, the results are presented as the mean
(X) ± standard deviation (SD). In the figures, the comparisons of the obtained results for body weight
and food and water intake were done with the Student’s t-test, with significant differences expressed as
p < 0.05, p < 0.01, and p < 0.001. The one-way ANOVA and post-hock analysis (i.e., Tuckey’s test), with
a level of statistical significance set at p < 0.05, were used to determine the differences in the severity of
the gastric damage score.
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